Japanese Doctors Warned Not To Give TamiFlu To Teens After Abnormal Behavior

Tokyo (AP) -- Japanese doctors are being warned not to prescribe TamiFlu for teenagers.

The emergency warning comes after several young patients using the flu-fighting drug reportedly exhibited dangerous behavior.

Officials say two teenagers taking the drug fell to their deaths and two others broke legs after jumping from their homes.

In the US, the FDA has said it's received more than 100 reports of delirium, hallucinations and other unusual psychiatric behavior in 2005 and 2006, mostly in Japanese children.

TamiFlu is widely used in Japan to treat influenza. It is also one of the few drugs believed to be effective in fighting Bird Flu.

The drug's maker says there's been no data linking the drug to abnormal behavior in young patients. Both the company (Roche Holding AG) and the FDA have said such symptoms could stem from severe cases of the flu.

Copyright 2007 by the Associated Press. All rights reserved.

Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to webmaster@wvlt-tv.com. Please provide detailed information.

powered by Disqus


6450 Papermill Drive Knoxville, TN 37919 Phone - (865) 450-8888; Fax - (865) 450-8869
Copyright © 2014 WVLT-TV Inc. - Designed by Gray Digital Media - Powered by Clickability 6635692 - local8now.com/a?a=6635692
Gray Television, Inc.